How to Cite
Abstract
Objetivo: Evaluar el efecto protector de la melatonina sobre células mononucleares de sangre periférica (CMSP) humana expuestas in vitro a radiación ionizante. Materiales y métodos: Las CMSP de donantes sanos fueron incubadas con melatonina en concentraciones de 0, 1x10-5, 1x10-6 y 1x10-7M durante 10 minutos antes de ser expuestas a rayos gamma (300cGy, fuente de Co60); posteriormente el daño del ADN fue evaluado mediante el Ensayo del Cometa. Resultados: Las CMSP pre-tratadas con melatonina presentaron cometas con colas de menor longitud que las no tratadas así como un porcentaje menor de células con daño severo del DNA. Conclusión: Concentraciones de melatonina de 1x10-5, 1x10-6 y 1x10-7 M protegen in vitro a las CMSP del daño en el ADN (rupturas de cadena sencilla y sitios lábiles al álcali) inducido por rayos gamma.
Palabras clave: células mononucleares sanguíneas, daño en el ADN, ensayo del Cometa, melatonina, radiación gamma
AbstractProtective action of melatonin on human peripheral blood mononuclear cells exposed to gamma radiation Co60. Objective: to evaluate the protective effect of melatonin on peripheral blood mononuclear cells (PBMCs) exposed in vitro to ionizing radiation. Materials and methods: PBMCs drawn from healthy volunteers were incubated with 0, 1x10-5, 1x10-6 y 1x10-7 M melatonin for 10 minutes before being exposed to gamma radiation (300 cGy; Co60 source). Afterwards, DNA damage was evaluated with the comet assay. Results: PBMCs pretreated with melatonin showed comet tails shorter than those without the hormone treatment, as well as a lower percentage of cells with severe DNA damage. Conclusion: melatonin doses of 1x10-5, 1x10-6 and 1x10-7 M provide in vitro protection to PBMCs from DNA damage (single strand breaks and alkali-labile sites) induced by gamma radiation (300 cGy; Co60 source).
Key words: blood mononuclear cells, comet assay, DNA damage, gamma radiation, melatonin
Resumo
Ação protetora da melatonina nas células mononucleares do sangue periférico humano submetido à radiação gama co60. Objetivo: Avaliar o efeito protetor da melatonina sobre células mononucleares do sangue periférico (CMSP) humano, expostas in vitro à radiação ionizante. Materiais e Métodos: As CMSP de pessoas sadias foram incubadas com melatonina em concentrações de 0,1x10-5, 1x10-6 y 1x10-7M durante 10 minutos antes de serem expostas a raios gama (300cGy, fonte de Co60); posteriormente, o dano do DNA foi avaliado mediante o Teste do Cometa. Resultados: As CMSP previamente tratadas com melatonina apresentaram cometas com caudas de menor comprimento que as não tratadas, assim como uma porcentagem menor de células com dano severo do DNA. Conclusões: Concentrações de melatonina de 1x10-5, 1x10-6 e 1x10-7M protegem in vitro as CMPS do dano no DNA (rupturas de cadeia simples e sítios débeis ao álcali) induzido pelos raios gama.
Palavras chave: Células mononucleares sangüíneas, dano no DNA, Teste do Cometa, melatonina, radiação gama.
Univ. Sci. is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights. Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.